HealthEquity, Inc. (NASDAQ:HQY) Shares Sold by State of Tennessee Department of Treasury

State of Tennessee Department of Treasury reduced its position in HealthEquity, Inc. (NASDAQ:HQY) by 2.7% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 26,900 shares of the company’s stock after selling 759 shares during the period. State of Tennessee Department of Treasury’s holdings in HealthEquity were worth $2,581,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also recently made changes to their positions in the company. Pier Capital LLC purchased a new position in HealthEquity during the fourth quarter valued at $8,024,000. HighTower Advisors LLC boosted its holdings in HealthEquity by 4.8% in the 4th quarter. HighTower Advisors LLC now owns 95,075 shares of the company’s stock worth $9,122,000 after buying an additional 4,370 shares during the last quarter. Geneva Capital Management LLC increased its stake in HealthEquity by 24.6% during the 4th quarter. Geneva Capital Management LLC now owns 1,048,903 shares of the company’s stock worth $100,642,000 after buying an additional 206,894 shares in the last quarter. Charles Schwab Investment Management Inc. raised its stake in HealthEquity by 2.4% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 1,086,811 shares of the company’s stock valued at $104,280,000 after purchasing an additional 25,004 shares during the last quarter. Finally, Wells Fargo & Company MN raised its position in shares of HealthEquity by 4.7% in the fourth quarter. Wells Fargo & Company MN now owns 124,940 shares of the company’s stock valued at $11,988,000 after buying an additional 5,594 shares during the last quarter. 99.55% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at HealthEquity

In related news, Director Robert W. Selander sold 5,750 shares of the business’s stock in a transaction on Monday, February 10th. The stock was sold at an average price of $111.29, for a total transaction of $639,917.50. Following the completion of the transaction, the director now directly owns 78,219 shares of the company’s stock, valued at $8,704,992.51. The trade was a 6.85 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Michael Henry Fiore sold 8,881 shares of the stock in a transaction dated Friday, April 4th. The shares were sold at an average price of $78.26, for a total value of $695,027.06. Following the completion of the sale, the executive vice president now directly owns 56,655 shares in the company, valued at $4,433,820.30. This represents a 13.55 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 20,381 shares of company stock worth $1,781,432. Corporate insiders own 2.20% of the company’s stock.

Analyst Upgrades and Downgrades

HQY has been the topic of a number of analyst reports. KeyCorp reduced their price objective on HealthEquity from $110.00 to $100.00 and set an “overweight” rating on the stock in a research report on Wednesday, April 16th. Wells Fargo & Company boosted their price target on shares of HealthEquity from $110.00 to $125.00 and gave the company an “overweight” rating in a research report on Wednesday, February 26th. Raymond James raised shares of HealthEquity from an “outperform” rating to a “strong-buy” rating and reduced their target price for the stock from $120.00 to $115.00 in a research note on Tuesday, March 25th. The Goldman Sachs Group dropped their price target on shares of HealthEquity from $107.00 to $94.00 and set a “neutral” rating for the company in a research note on Thursday, March 27th. Finally, Barrington Research reaffirmed an “outperform” rating and set a $112.00 price target on shares of HealthEquity in a research report on Friday, April 11th. One research analyst has rated the stock with a hold rating, ten have assigned a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Buy” and an average target price of $111.75.

HealthEquity Stock Performance

NASDAQ HQY opened at $85.87 on Monday. The company has a debt-to-equity ratio of 0.51, a current ratio of 3.20 and a quick ratio of 3.20. The company has a market cap of $7.43 billion, a P/E ratio of 78.78, a P/E/G ratio of 1.60 and a beta of 0.49. The stock has a 50-day moving average of $91.87 and a two-hundred day moving average of $96.59. HealthEquity, Inc. has a 1-year low of $65.01 and a 1-year high of $115.59.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.